Atara sees filing for FDA approval of Tab-cel in Q2 2024 (ATRA)
Iryna Drozd Atara Biotherapeutics (NASDAQ:ATRA) said that after meeting with the FDA, it now plans to submit the Biologics License ...
Monday, February 10, 2025
Tag: ATRA
RECOMMENDED
Get the latest news and follow the coverage of Investing, World News, Stocks, Market Analysis, Business & Financial News, and more from the top trusted sources.